|
|
Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study.
N. Vey
,
X. Thomas
,
C. Picard
,
T. Kovascovicz
,
C. Charin
et al.
Journal articles
hal-00453293v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs
C Faucher
,
A Le Corroller Soriano
,
B Esterni
,
N. Vey
,
A Stoppa
et al.
Journal articles
inserm-02294378v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
et al.
Journal articles
hal-03623367v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study
A. Collignon
,
M. A Hospital
,
C. Montersino
,
F. Courtier
,
A. Charbonnier
et al.
Journal articles
inserm-03038330v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
J. Gertner-Dardenne
,
R. Castellano
,
Emilie Mamessier
,
S. Garbit
,
E. Kochbati
et al.
Journal articles
hal-01765650v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse.
S. Park
,
N. Chapuis
,
Franck Saint-Marcoux
,
C. Recher
,
T. Prebet
et al.
Journal articles
hal-00849677v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.
Audrey Benyamine
,
A. Le Roy
,
Emilie Mamessier
,
J. Gertner-Dardenne
,
C. Castanier
et al.
Journal articles
inserm-01416288v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia.
C. Récher
,
M. C. Béné
,
B. Lioure
,
A. Pigneux
,
N. Vey
et al.
Journal articles
hal-00979453v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts
V. Gelsi-Boyer
,
N. Cervera
,
François Bertucci
,
M. Brecqueville
,
P. Finetti
et al.
Journal articles
hal-03623773v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia
S. Maury
,
S. Chevret
,
X. Thomas
,
D. Heim
,
T. Leguay
et al.
Journal articles
hal-01812704v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
M Duchmann
,
B Braun
,
J.B. Micol
,
P Platzbecker
,
P. Park
et al.
Journal articles
hal-01655936v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
et al.
Journal articles
hal-03376715v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase
M. Brecqueville
,
J. Rey
,
R. Devillier
,
A. Guille
,
R. Gillet
et al.
Journal articles
hal-03634242v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A conditioning platform based on fludarabine, busulfan and two days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
R. Devillier
,
S. Fürst
,
R. Crocchiolo
,
J. El-Cheikh
,
L. Castagna
et al.
Journal articles
hal-00903457v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia
M. Bonnet
,
M. Loosveld
,
B. Montpellier
,
Navarro J.M.
,
B. Quillichini
et al.
Blood, 2011, 117, pp.6650-6659
Journal articles
hal-00616996v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
C. Berthon
,
E. Raffoux
,
X. Thomas
,
N. Vey
,
C. Gomez-Roca
et al.
Journal articles
hal-01791279v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|